Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Anti-CD25 Immunotherapy: Regulating the Regulators.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.
B Cells in Pregnancy: Functional Promiscuity or Tailored Function?
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
The diagnosis of multiple sclerosis.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Smoking and inflammation: evidence for a synergistic role in chronic disease.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Clinical designs of recent robot rehabilitation trials.
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
[New treatment options in multiple sclerosis and their complications].
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Brain circuitry outside the synaptic cleft.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Pages
« first
‹ previous
…
226
227
228
229
230
231
232
233
234
…
next ›
last »